• A Virus Shortage? BlueBird Bio Buys A Factory To Make Its Own

    Nov 29, 2017, 11:14 AM by Michael Croft
    Forbes | Amid a reported shortage of the disabled viruses used for gene therapies, BlueBird Bio has purchased a 125,000-square-foot facility in Durham, North Carolina, that it will use for manufacturing the lentiviral vectors used in its treatments.
    Full story

  • AI Exposes Patterns For Faster Drug Discovery

    Nov 29, 2017, 09:20 AM by Michael Croft

    Bio-IT World Contributed Commentary | Though the results are just starting to emerge, AI is showing positive traction in drug development. Machine learning in particular can help pharma recover the value of repurposed drugs by finding new therapeutic applications for them.

    Full story

  • Tjoapack launches new bottle packing line

    Nov 29, 2017, 05:48 AM by Michael Croft
    ETTEN-LEUR, NETHERLANDS - Nov 29, 2017 - Contract packaging organisation (CPO), Tjoapack, has launched its new bottle packing line following a major investment earlier this year
    Full story

  • Tissue Science and Regenerative Medicine

    Nov 29, 2017, 05:44 AM by Michael Croft
    SYDNEY, AUSTRALIA - Jul 13, 2018 - 9th International Conference on Tissue Science and Regenerative Medicine is mainly based on the theme “Exploring the frontiers in tissue science and Medicine’’ We warmly welcome all the participants of world’s leading Scientists, Researchers and Scholars
    Full story

  • RxTE Health Appoints Senior Vice President of Clinical Operations

    Nov 28, 2017, 12:47 PM by Michael Croft
    SILICON VALLEY, CA, UNITED STATES - Nov 28, 2017 - RxTE Health (RxTE), a company specializing in pharmacy cost reduction programs for employers, today announced that it has expanded its executive team with the addition of Sara Linnerooth, PharmD, as Senior Vice President of Clinical Operations
    Full story

  • Recipharm awarded for growth in France

    Nov 28, 2017, 10:58 AM by Michael Croft
    FONTAINE, FRANCE - Nov 27, 2017 - Recipharm, a leading contract development and manufacturing organisation (CDMO), has received recognition for its commitment to its French operations
    Full story

  • Recipharm equips a further three facilities for US serialisation

    Nov 28, 2017, 10:05 AM by Michael Croft
    , SWEDEN - Nov 27, 2017 - Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its facilities with serialisation capabilities in line with the US regulatory requirements in time for today’s introduction of the Drug Supply Chain Security Act (DSCSA)
    Full story

  • A Grim Future? Here Are the Numbers

    Nov 28, 2017, 09:34 AM by Michael Croft
    In the Pipeline | Here's a bracing look at the state of the pharma business, especially regarding R&D costs and return on investment. And let me warn you - it's not a feel-good outlook.
    Full story

  • 750 Raspberry Pis Turned Into Supercomputer for Los Alamos National Laboratory

    Nov 28, 2017, 09:00 AM by Michael Croft
    ExtremeTech | A new project at the Los Alamos National Laboratory's High Performance Computing Division seeks to make supercomputers more accessible with help from Raspberry Pi clusters.
    Full story

  • WIRB-Copernicus Group Acquires Vigilare International

    Nov 28, 2017, 08:43 AM by Michael Croft
    PRINCETON, NJ - Nov 28, 2017 - WIRB Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of Vigilare International, the top provider of integrated, end-to-end pharmacovigilance and drug safety solutions for the biopharmaceutical and biotech industry
    Full story

  • Gene Therapy Hits A Peculiar Roadblock: A Virus Shortage

    Nov 27, 2017, 16:05 PM by Michael Croft
    The New York Times | Revolutionary new treatments depend on tailor-made viruses, but laboratories cannot make them fast enough.
    Full story

  • AMP/ASCO/CAP Variant Guidelines Integrated into NGS variant interpretation

    Nov 27, 2017, 15:26 PM by Michael Croft
    ESPOO, FINLAND - Nov 27, 2017 - Finnish bioinformatics firm, Euformatics has released an improved version of its CE-marked omnomicsNGS software that incorporates the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
    Full story

  • Three IT Tracks At Tri-Con Dig Deep Into Cloud, Data Commons, FAIR Data

    Nov 27, 2017, 12:55 PM by Michael Croft

    Bio-IT World | The Molecular Medicine Tri-Conference will celebrate its 25th anniversary next February in San Francisco. Here are a few of the talks coming from the conference we’ve marked so far.

    Full story

  • Lexogen and Partek Deliver QuantSeq Analysis Solution

    Nov 27, 2017, 12:43 PM by Michael Croft
    ST. LOUIS AND VIENNA, MO, UNITED STATES AND GERMANY - Nov 28, 2017 - Partek and Lexogen scientists have joined forces to deliver an easy-to-use analysis pipeline in Partek® Flow® software for data generated by Lexogen’s QuantSeq 3’ Library Prep Kits
    Full story

  • Senator Calls For More Scrutiny Of Home DNA Test Industry

    Nov 27, 2017, 09:10 AM by Michael Croft
    NBC News | With the holiday season in full swing, Sen. Chuck Schumer said customers may be putting their genetic information at risk of being sold to third parties.
    Full story

  • Multiple Myeloma Data Analysis Shows Need For Diversity In Research

    Nov 22, 2017, 15:50 PM by Michael Croft
    Bio-IT World | An analysis of data from the Multiple Myeloma Research Foundation (MMRF) CoMMpass study by researchers from the Keck School of Medicine of the University of Southern California (USC) Department of Translational Genomics found significant genetic mutation differences between African Americans and Caucasians with multiple myeloma. African American patients showed increased mutations in genes previously unassociated with multiple myeloma. The findings were published today in PLoS Genetics.
    Full story

  • Tackling The Internet Of Things In Healthcare

    Nov 22, 2017, 08:15 AM by Michael Croft

    Bio-IT World | Cambridge Healthtech Institute's Inaugural Healthcare Internet of Things event in San Francisco next February aims to bring together constituents and stakeholders to share cases studies and pilot programs that showcase the healthcare industry’s collaborative efforts toward the adoption and implementation of IoT. Here are a few of the talks we have flagged on our agendas.

    Full story

  • Sensors Could Identify Biomarkers, Improve Early-Stage Detection, Treatment Of Diseases

    Nov 21, 2017, 12:00 PM by Michael Croft

    Bio-IT World Brief | Purdue University researchers have found a method of identifying biological markers in small amounts of blood that they believe could be used to detect a myriad of diseases, infections, and different medical conditions at early stages.

    Full story

  • Creative Biolabs Launches Membrane Protein Antibody Discovery Service

    Nov 20, 2017, 04:29 AM by Michael Croft
    SHIRLEY, NY - Nov 20, 2017 - Growing interest is focusing on the potential of membrane protein as a breaking point of antibody-based therapy and diagnosis for various diseases
    Full story

  • Gene Drives Aren’t Safe Enough To Trial Right Now

    Nov 17, 2017, 13:50 PM by Michael Croft
    MIT Technology Review | Technology's answer to invasive species and disease-spreading insects is looking riskier than ever in its current form.
    Full story